Establishing Referral Laboratory Testing Governance and Addressing "Miscellaneous" Test Orders across an Academic Health System.

IF 1.8 Q3 MEDICAL LABORATORY TECHNOLOGY Journal of Applied Laboratory Medicine Pub Date : 2025-01-03 DOI:10.1093/jalm/jfae121
Allison B Chambliss, Joshua L Deignan, Charlemagne Isip, Monique Trinh, William Werre, Alyssa Ziman
{"title":"Establishing Referral Laboratory Testing Governance and Addressing \"Miscellaneous\" Test Orders across an Academic Health System.","authors":"Allison B Chambliss, Joshua L Deignan, Charlemagne Isip, Monique Trinh, William Werre, Alyssa Ziman","doi":"10.1093/jalm/jfae121","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Referral (send-out) laboratories support clinical needs but may cause issues for hospitals or health systems related to regulations and governance, specimen logistics, test result availability, and cost and reimbursement. The use of a \"miscellaneous\" referral test order can increase risks of specimen collection or processing errors, result delays, and repeat testing.</p><p><strong>Methods: </strong>We established an approved referral laboratory test list and a digital form for providers to request new referral tests. We collated laboratory stewardship committee decisions over a 20-month period. Separately, we retrospectively reviewed referral tests ordered as miscellaneous across our health system over 1 year. Subject matter experts identified appropriate tests to build as discretely orderable in the electronic health record. Following targeted provider notification of the new tests, we assessed their uptake and impact on result turnaround times for the first 5 built tests over 6 months.</p><p><strong>Results: </strong>Our laboratory stewardship committee approved 16 of 27 provider requests to build new referral tests over the first 20 months following implementation of the new request process. In addition, 37 of the 100 most frequently ordered miscellaneous tests were recommended to be built as discrete orders. Uptake of the first 5 built tests (relative to providers continuing to use miscellaneous orders) averaged 64% over the first 6 months. Result turnaround times improved by an average of 1.1 days when the discrete orders were used.</p><p><strong>Conclusions: </strong>We successfully established oversight of referral laboratory testing across our health system, pivoted orders away from miscellaneous, and observed improvements in turnaround times.</p>","PeriodicalId":46361,"journal":{"name":"Journal of Applied Laboratory Medicine","volume":"10 1","pages":"4-12"},"PeriodicalIF":1.8000,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Applied Laboratory Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jalm/jfae121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Referral (send-out) laboratories support clinical needs but may cause issues for hospitals or health systems related to regulations and governance, specimen logistics, test result availability, and cost and reimbursement. The use of a "miscellaneous" referral test order can increase risks of specimen collection or processing errors, result delays, and repeat testing.

Methods: We established an approved referral laboratory test list and a digital form for providers to request new referral tests. We collated laboratory stewardship committee decisions over a 20-month period. Separately, we retrospectively reviewed referral tests ordered as miscellaneous across our health system over 1 year. Subject matter experts identified appropriate tests to build as discretely orderable in the electronic health record. Following targeted provider notification of the new tests, we assessed their uptake and impact on result turnaround times for the first 5 built tests over 6 months.

Results: Our laboratory stewardship committee approved 16 of 27 provider requests to build new referral tests over the first 20 months following implementation of the new request process. In addition, 37 of the 100 most frequently ordered miscellaneous tests were recommended to be built as discrete orders. Uptake of the first 5 built tests (relative to providers continuing to use miscellaneous orders) averaged 64% over the first 6 months. Result turnaround times improved by an average of 1.1 days when the discrete orders were used.

Conclusions: We successfully established oversight of referral laboratory testing across our health system, pivoted orders away from miscellaneous, and observed improvements in turnaround times.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
建立转诊实验室测试治理和解决跨学术卫生系统的“杂项”测试命令。
背景:转诊(送出)实验室支持临床需求,但可能给医院或卫生系统带来与法规和治理、标本物流、检测结果可用性以及成本和报销相关的问题。使用“杂项”转诊检测命令会增加标本采集或处理错误、结果延迟和重复检测的风险。方法:我们建立了一份经批准的转诊实验室检测清单和一份数字表格,供提供者申请新的转诊检测。我们在20个月的时间里整理了实验室管理委员会的决定。另外,我们回顾性地审查了1年来在我们的卫生系统中订购的杂项转诊检查。主题专家确定了在电子健康记录中建立可离散订购的适当测试。在有针对性的提供商通知新测试之后,我们评估了它们在6个月内对前5个构建测试的结果周转时间的吸收情况和影响。结果:在实施新的请求流程后的头20个月内,我们的实验室管理委员会批准了27个供应商建立新的转诊检测的请求中的16个。此外,在100个最常订购的杂项测试中,建议将37个作为离散订单建造。前6个月,前5个构建测试(相对于继续使用杂项订单的提供商)的平均使用率为64%。结果周转时间提高了平均1.1天,当离散的订单被使用。结论:我们成功地在整个卫生系统中建立了对转诊实验室检测的监督,减少了繁杂的订单,并观察到周转时间的改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Applied Laboratory Medicine
Journal of Applied Laboratory Medicine MEDICAL LABORATORY TECHNOLOGY-
CiteScore
3.70
自引率
5.00%
发文量
137
期刊最新文献
Measurement of Whole Blood Tacrolimus Concentrations by LC-MS/MS and Immunoassay Methods: Influence of Immediate-Release vs Extended-Release Tacrolimus Formulations. Adrenal Venous Sampling in the Investigation of Hyperaldosteronism: A Retrospective Practice Review from a Large Academic Medical Center. An Introduction to the Complete Blood Count for Clinical Chemists: White Blood Cells. Electric Trends of Laboratory Medicine: Five Years of Growth, Visibility, and Opportunity. Analytical Validation and Performance of a Blood-Based P-tau217 Diagnostic Test for Alzheimer Disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1